Articles tagged with Rna Binding Proteins
Researchers identify nonsense-mediated mRNA decay (NMD) as a central mediator of neuronal migration and cortical lamination. The study reveals that UPF2, a core component of NMD machinery, is essential for proper neuron migration and brain development.
Glycosylated RNAs on the cell surface form clusters with RNA binding proteins, regulating interactions with surrounding growth factors and controlling angiogenesis. The study found that altering the amount of RNA on the cell surface can modify intracellular signaling cascades through selective interaction with growth factors.
Researchers discovered that brain enzyme OTULIN regulates tau protein accumulation and has implications for treating neurodegenerative diseases. The study revealed OTULIN's role in controlling gene expression and RNA metabolism, suggesting a potential therapeutic target.
Researchers have developed a technology that maps the entire network of RNA-protein interactions inside human cells, offering new strategies for treating diseases like cancer and Alzheimer's. The study uncovered over 350,000 interactions, including many that had never been seen before.
A team from The Hebrew University of Jerusalem has developed innovative druglike molecules capable of degrading HuR, a key RNA-binding protein that stabilizes oncogenes and fuels cancer progression. These molecular degraders improve anticancer properties by up to 3-4 orders of magnitude compared to traditional HuR-binding molecules.
Researchers discovered that METTL3, an oncogene, regulates the expression of SMAD4 via miR-146a-5p in OSCC. This pathway can potentially have therapeutic implications for treating oral squamous cell carcinoma.
Researchers have discovered a new druggable cancer target, NPM1, which is expressed on the surface of malignant AML cells. Monoclonal antibodies targeting NPM1 showed robust anti-tumor activity in multiple in vivo models of AML, with no apparent toxicity to non-cancerous blood cells and stem cells.
Myotonic Dystrophy Type 1 affects multiple organs, including the heart, and is caused by a mutation in the DMPK gene that leads to disrupted RNA processing. Researchers at Baylor College of Medicine tested MBNL overexpression in a mouse model, achieving partial rescue of cardiac phenotypes.
A new study using single-cell transcriptome analysis investigated the expression and dysregulation of RNA-binding proteins in rheumatoid arthritis. The research found that RBP regulation differs between RA and osteoarthritis, with specific RBPs involved in alternative mRNA splicing and translational control.
Scientists at HIRI have made significant progress through a series of in vitro and in vivo experiments, revealing a complex RNA-based regulatory circuit governing PUL expression in B. thetaiotaomicron.
Researchers from Institute of Science Tokyo discovered that tristetraprolin (TTP) regulates inflammatory responses in basophils by promoting mRNA degradation. In TTP-deficient mice, aggravated allergic inflammation was observed, suggesting TTP as a key regulator of basophil-mediated immune responses.
Researchers at U of T have discovered that C2H2 zinc finger proteins, which primarily bind to DNA, also regulate RNA processing through various mechanisms. These proteins modify mRNA, controlling its length and altering it after transcription.
Dr. Jeetain Mittal's NIH grant will support multiscale computational models investigating phase separation in biology, particularly heterochromatin formation and its role in neurodegenerative diseases. The research aims to elucidate the molecular origins of phase separation using innovative models and methods.
A specific protein, TRBP, regulates the balance between apoptosis and interferon response to suppress viral replication. This study sheds light on a previously unclear mechanism of defense against viruses in mammalian cells.
Researchers developed a prediction tool to classify proteins based on their potential to bind RNA G-quadruplexes, showing high protein disorder and hydrophilicity. This discovery provides insights into gene expression and phase-separation into membrane-less organelles.
Scientists at the University of California, Riverside, have identified 898 RNA-dependent proteins in the deadliest human malaria parasite, Plasmodium falciparum. These findings could lead to novel therapeutic targets against malaria and highlight the importance of RNAs in biological pathways in the parasite.
A team of researchers from Texas Heart Institute and Baylor College of Medicine have made a significant discovery about the underlying molecular cell states within transplanted pediatric hearts. They found that donor-derived tissue-resident macrophages are crucial for graft acceptance, but their loss leads to allograft failure.
Researchers aim to decipher function and structure of 1,000 RNA-binding proteins involved in mRNA transport. They hope to gain insights into mRNA stability, relevant to new vaccine development and cancer research.
A new study reveals that RNA binding motif protein X-linked (RBMX) plays a crucial role in predicting cancer prognosis and response to immunotherapy. Abnormal expression of RBMX is associated with immune regulation, tumor microenvironment, and therapeutic effects of immune checkpoint inhibitors.
Researchers found that the loss of RBFOX2 protein leads to increased cell migration, invasion, tumor development, and metastasis in pancreatic cancer. The study suggests alternative RNA splicing plays a critical role in pancreatic cancer progression.
Researchers found a code directing mRNAs to specific neighborhoods for translation, revealing the cytoplasm's compartmentalization. This discovery sheds light on fundamental cellular biology and holds promise for increasing or altering protein production in mRNA vaccines and therapies.
Researchers uncover the role of IGF2BP2 in responding to cardiac stress, highlighting its potential reversibility and clinical relevance. Elevated IGF2BP2 expression leads to dilated cardiomyopathy, but controlled reduction prompts recovery.
Human SIDT1 and SIDT2 proteins form dimers and higher-order oligomers to bind small RNAs in a pH-dependent manner, enabling their transport into the cytoplasm. This study elucidates the molecular basis of RNA uptake by these proteins, shedding light on their functional regulation.
Rice University scientists developed a tiny CRISPR-Cas13 system to shred viruses by targeting RNA. The system's unique mechanism and three-dimensional structure were mapped using cryo-electron microscopy, allowing researchers to engineer it for improved precision and specificity.
Researchers discovered that inhibiting IGF2BP1 can extinguish its cancer-causing effects, leading to the formation of neuroblastomas. The study provides a promising new potential therapeutic approach for treating this childhood cancer.
Increased expression of Musashi 1 on breast cancer cells has significant implications for understanding dormancy and survival in bone marrow. Msi 1 knockdown led to a reduction in cancer stem cells with undetectable PD-L1, suggesting a potential therapeutic target.
Researchers found that when FXR1 is absent, vascular smooth muscle cells proliferate more slowly, become senescent, and scar tissue development is reduced. This suggests that drugs targeting FXR1 may treat vascular proliferative diseases such as atherosclerosis, restenosis, hypertension, and abdominal aortic aneurysm.
A specialized mRNA translation circuit controlled by protein RBPMS determines the competence for heart formation in human embryonic development. The study provides a better understanding of human cardiac development and reveals potential molecular targets for therapeutic interventions.
Researchers at Kyoto University discovered METTL16's role in DNA repair and erythropoiesis, a process generating 200 billion new red blood cells daily. Tiny methyl groups on specific mRNAs play a pivotal role in this process, involving mechanisms mediated by RNA-binding proteins.
A team of researchers from Ritsumeikan University in Japan has elucidated the mechanism behind the liquid-solid phase transition of FUS protein that leads to ALS. They discovered a new therapeutic target, arginine, which suppresses FUS aggregation and could delay ALS progression.
Researchers at the Centre for Genomic Regulation have identified PDIA6 as a key protein involved in driving melanoma malignancy. The study found that PDIA6 promotes melanoma cell growth by binding to RNA molecules inside tumor cells, making it a promising therapeutic target.
Researchers at LMU demonstrate that Staufen2 and Argonaute proteins form RNA granules that compete with each other to regulate protein translation in neurons. This competition regulates synaptic plasticity, particularly in dendrites and synapses, contributing to learning and memory.
Researchers discovered common mutations and dysfunction in myotonic dystrophy type 1 and Rett syndrome using brain organoids. The study suggests that targeting NMDA receptors may ameliorate cognitive impairments in young patients with DM1.
Researchers at EMBL discovered how messenger RNA molecules bind to and regulate the enzyme ENO1, which breaks down glucose. This riboregulation process can determine cell growth and differentiation, with potential implications for understanding cancer.
Researchers at the Babraham Institute found that two RNA binding proteins, ZFP36 and ZFP36L1, play a crucial role in T cell development and function. The absence of these proteins enhances the potency of T cells during viral infections, leading to improved cytotoxic immune responses.
Scientists have identified over 100 phosphorylation sites with regulatory potential on RNA-binding proteins, including RBM20, which plays a crucial role in titin synthesis and heart muscle diseases. These findings provide insight into the post-transcriptional regulation of gene expression.
Researchers led by Cynthia Sharma explore a vast universe of RNA-binding proteins in bacteria, which play crucial roles in stress response and virulence control. The team aims to advance understanding of these proteins, revealing fundamental biological principles that could lead to novel biotechnological methodologies or antimicrobial ...
Researchers uncover the pleiotropic functions of hnRNPK in regulating skeletal muscle cell differentiation, including inhibition of myoblast differentiation and suppression of genes involved in endoplasmic reticulum stress. The study suggests that targeting hnRNPK could be a potential therapeutic strategy for treating human disorders.
Researchers at Karolinska Institutet have identified a specific connection between a protein and an lncRNA molecule that can help decrease fat depots in tumor cells, leading to cell division cessation and cancer cell death. The study contributes to increased knowledge of liver cancer diagnosis and future treatments.
Researchers at WVU are studying the Musashi proteins to understand their role in retinal degeneration and develop a universal therapy. By investigating protein translation and gene suppression, they hope to identify potential pathways to boost protein production and slow vision loss.
Researchers at the University of Alabama at Birmingham discovered a small molecule that potently attenuates neuroinflammation in brain and glial cells. This finding presents a promising new approach to treat neurological diseases driven by neuroinflammation, such as stroke, spinal cord injury, and neuropathic pain.
Researchers at MUSC have discovered that hnRNP E1, a tumor suppressor protein, not only binds RNA but also DNA to maintain genome integrity and sense or prevent DNA damage. The protein's binding is sequence- and structure-specific, suggesting its potential role in preventing cancer metastasis.
Researchers at The Francis Crick Institute successfully reversed a key hallmark of motor neurone disease by blocking the activity of an enzyme called VCP. This breakthrough, published in Brain Communications, suggests that the abnormal accumulation of proteins involved in RNA regulation might be a factor contributing to the disease.
Researchers discovered RNA-binding proteins, particularly YTHDF2, as potential targets for treating triple-negative breast cancer. Inhibiting these proteins may provide a new approach to halting tumor growth and reduce adverse side effects.
Researchers from LMU have identified two RNA-binding proteins that regulate synaptic transmission in distinct ways, controlling mRNA levels and translation. These findings provide insight into the mechanisms of neurological disorders such as epilepsy and autism.
A recent study has deepened our understanding of the SARS-CoV-2 nucleocapsid protein's interactions with genetic material, offering potential avenues for developing effective treatments. The research reveals how the N protein binds to RNA and protects it, and highlights its flexibility as a key factor in this process.
Researchers at Case Western Reserve University have found a way to measure the kinetics of proteins that bind to RNA, shedding light on gene function regulation in diseases like cancer and neurodegenerative disorders. This discovery could lead to new therapeutic strategies targeting RNA-protein interactions.
A new study found a correlation between RNA-binding protein clumping and protein aggregates in the hearts of patients with RBM20 dilated cardiomyopathy. This discovery suggests that RBM20 is an RNA-binding protein granule disease similar to Lou Gehrig's disease and Alzheimer's disease.
Scientists have discovered a key mechanism behind SINEUPs, which can amplify protein production by messenger RNAs. The research provides new insights into how these functional non-coding RNAs work and their potential to treat diseases caused by insufficient protein synthesis.
The study reveals a unique RNA binding pocket in SARS-CoV-2 nucleocapsid protein, which could guide the design of novel antiviral agents. The crystal structure provides atomic resolution features that may lead to the development of specific targeting sites for SARS-CoV-2.
Researchers have identified many genome locations that code for RNA molecules influencing gene expression, using techniques like eCLIP and RNA Bind-N-Seq. The study reveals the functions of these RNA sequences and their interactions with RNA-binding proteins.
Researchers from UC San Diego School of Medicine contributed to the ENCODE project, describing millions of candidate DNA switches that regulate gene expression. The study reveals novel functions for RNA-binding proteins and identifies genetic elements linked to human disease risk variants.
Researchers at UC San Diego identified a new RNA-binding protein that regulates plant immune responses, enabling rapid on and off signals to fight pathogens. The discovery provides insights into the complex mechanisms of plant defense and paves the way for improved disease resistance and food security.
The RNA-binding protein ProQ plays a crucial role in the activation of over 250 bacterial genes, enabling meningococci to repair DNA and resist oxidative stress. Understanding its function is key to developing new antibacterial agents.
Researchers investigated how stress granules assemble and dissolve, shedding light on their role in neurodegenerative diseases like ALS. Stress granules formed in response to stress can promote the assembly of dynamic structures that may trigger motor neuron death.
A new AI-powered computational tool, NucleicNet, has been developed to infer RNA-binding properties of proteins. The software provides additional biological insights that could aid in drug design and development, by revealing detailed RNA-binding properties of these proteins.
A new research training group will investigate intrinsically disordered proteins, crucial for human function and disease development. The group aims to unravel protein structures and functions using state-of-the-art techniques.
Researchers found a critical structure within TDP-43 that causes nerve cell death in ALS and FTD. Modifying this structure could lead to new therapies for these devastating diseases.
Researchers discovered that impaired FUS protein-protein interactions contribute to ALS degeneration, but drug-induced autophagy reduces pathological processes linked to aberrantly accumulated FUS. Stimulating autophagy rescued RNA-binding proteins and reduced neuronal death in cell culture experiments.
Scientists at Hebrew University create decoy molecules that trick RNA-binding proteins into binding with them, inhibiting their cancer-promoting activity. The technology has shown promise in slowing or stopping the growth of brain and breast cancer cells in mice.